Here's Why USA Rare Earth Stock Crashed in November

USA Rare Earth shares plunged 30.8% in November after China paused proposed rare-earth export controls that had driven an October rally on expectations of U.S. support and alternative supply deals. The company plans to manufacture rare-earth magnets in Stillwater, Oklahoma, controls Round Top Mountain mineral rights in Texas but is prioritizing non-China supply chains, and has acquired UK-based Less Common Metals (LCM); LCM then signed a supply agreement with Solvay and Arnold Magnetic Technologies expected to generate revenue. The pause in Chinese export curbs triggered investor outflows, but the LCM acquisition and subsequent supply deals materially derisk the firm’s supply-chain thesis for investors willing to bear high risk.

Analysis

Market structure: A China-centric supply base (90%+ of magnets) means geopolitical headline risk will continue to redistribute economic rents to any credible non-Chinese supplier. Near-term winners are incumbents with tangible off‑China feedstocks or offtake (MP, LCM/USAR partners, Arnold, Solvay); losers are pure‑play OEMs exposed to sudden input shortages and speculative juniors without contracts. Expect equity volatility in juniors to remain +30–100% vs. broader materials names on headline days; modestly higher capex issuance for project developers should pressure high‑yield spreads by 50–150bp if large financing windows open.

Risk assessment: Tail outcomes include (A) China enacting strict export controls causing rare‑earth price spikes of +50–200% and forcing immediate OEM rationing, which benefits contracted domestic suppliers; (B) USAR/peers failing to scale or diluting equity in a 20–40% financing, leaving shareholders severely impaired. Immediate (days) moves will be headline driven (±20–40%), short term (3–12 months) depends on contract wins and DOE/DoD awards, long term (2–5 years) hinges on mine buildout and magnet plant throughput.

Trade implications: Tactical positions: establish small, size‑controlled long exposure to USAR and larger to MP — e.g., 2–3% portfolio long USAR contingent and 1–2% overweight MP — with stop at 30% drawdown and review at 6 months. Use 9–12 month call spreads on USAR (buy 12‑month ATM call, sell 18–24% OTM) to play upside while capping premium; consider covered calls on MP to monetize elevated implied vol. Rotate 0.5–1% from broad materials into domestic magnet supply chain names if Congress/DoD signals funding within 90 days.

Contrarian angles: Market likely overprices headline volatility and underprices executed supply contracts — the LCM acquisition plus Solvay/Arnold supply deals materially reduce execution risk versus pure explorers. If US federal procurement grants exceed $100m to a single supplier (or DoD procurement contracts >$50m) within 6–12 months, re‑rate potential is >50% for contracted, operational names; conversely, a prolonged pause in Chinese controls without US policy support keeps juniors depressed and creates buying opportunities under 40% of replacement‑cost expectations.

Key Decisions for Investors

• Establish a size‑constrained long position in USAR equal to 2–3% of portfolio risk capital only if entry occurs at ≥30% below October highs (or implied vol >2x peers); set a hard stop‑loss at 30% and cap holding period to 6–12 months unless company secures >$50m in confirmed contracts.
• Increase exposure to MP Materials (MP) by 1–2% overweight as a lower‑beta domestic play; write 6–9 month covered calls at a 10–20% OTM strike to harvest premium while maintaining upside participation.
• Buy 9–12 month call spreads on USAR (buy ATM, sell ~+18–24% OTM) sized for 0.5–1% portfolio risk to capture upside on policy or contract catalysts while limiting theta decay.
• Reallocate 0.5–1% from general materials into supply‑chain contractors (Arnold Magnetic Technologies, Solvay‑linked names, LCM exposures) if within 90 days the US DoD/DOE issues RFPs or announces grants; if no policy movement in 120 days, trim these positions by 50%.
• Avoid funding‑round participation in non‑contracted juniors unless post‑money valuation implies >50% upside at parity to replacement cost; require demonstrable customer LOI or >$20m committed prepayment before adding exposure.